GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (AMEX:CATX) » Definitions » Cyclically Adjusted PB Ratio

Perspective Therapeutics (Perspective Therapeutics) Cyclically Adjusted PB Ratio : 4.79 (As of Apr. 28, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Perspective Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Perspective Therapeutics's current share price is $1.58. Perspective Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $0.33. Perspective Therapeutics's Cyclically Adjusted PB Ratio for today is 4.79.

The historical rank and industry rank for Perspective Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

CATX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.62   Med: 1.63   Max: 9.33
Current: 4.72

During the past years, Perspective Therapeutics's highest Cyclically Adjusted PB Ratio was 9.33. The lowest was 0.62. And the median was 1.63.

CATX's Cyclically Adjusted PB Ratio is ranked worse than
78.51% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs CATX: 4.72

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Perspective Therapeutics's adjusted book value per share data for the three months ended in Dec. 2023 was $0.267. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.33 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perspective Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Perspective Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Cyclically Adjusted PB Ratio Chart

Perspective Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 2.24 3.05 1.01 1.20

Perspective Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 1.98 2.03 0.82 1.20

Competitive Comparison of Perspective Therapeutics's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Perspective Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perspective Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's Cyclically Adjusted PB Ratio falls into.



Perspective Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Perspective Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.58/0.33
=4.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Perspective Therapeutics's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.267/129.4194*129.4194
=0.267

Current CPI (Dec. 2023) = 129.4194.

Perspective Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.455 99.695 0.591
201406 0.438 100.560 0.564
201409 0.427 100.428 0.550
201412 0.410 99.070 0.536
201503 0.394 99.621 0.512
201506 0.378 100.684 0.486
201509 0.361 100.392 0.465
201512 0.337 99.792 0.437
201603 0.319 100.470 0.411
201606 0.298 101.688 0.379
201609 0.272 101.861 0.346
201612 0.247 101.863 0.314
201703 0.223 102.862 0.281
201706 0.193 103.349 0.242
201709 0.166 104.136 0.206
201712 0.143 104.011 0.178
201803 0.120 105.290 0.148
201806 0.089 106.317 0.108
201809 0.165 106.507 0.200
201812 0.144 105.998 0.176
201903 0.128 107.251 0.154
201906 0.114 108.070 0.137
201909 0.103 108.329 0.123
201912 0.091 108.420 0.109
202003 0.086 108.902 0.102
202006 0.083 108.767 0.099
202009 0.074 109.815 0.087
202012 0.146 109.897 0.172
202103 0.481 111.754 0.557
202106 0.475 114.631 0.536
202109 0.463 115.734 0.518
202112 0.453 117.630 0.498
202203 0.445 121.301 0.475
202206 0.431 125.017 0.446
202209 0.406 125.227 0.420
202212 0.387 125.222 0.400
202303 0.424 127.348 0.431
202306 0.387 128.729 0.389
202309 0.352 129.860 0.351
202312 0.267 129.419 0.267

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perspective Therapeutics  (AMEX:CATX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Perspective Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perspective Therapeutics (Perspective Therapeutics) Business Description

Traded in Other Exchanges
Address
350 Hills Street, Suite 106, Richland, WA, USA, 99354
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.
Executives
Williamson Robert F Iii director 140 LASALLE AVENUE, PIEDMONT CA 94610
Markus Puhlmann officer: Chief Medical Officer 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Jonathan Robert Hunt officer: Chief Financial Officer 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Lori A Woods officer: Vice President 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Heidi Henson director 2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD CA 92008
Frank Morich director 40 GUEST STREET, BOSTON MA 02135
Johan M. Spoor director, officer: CEO 500 BOYLSTON STREET, SUITE 1600, BOSTON MA 02116
Mark John Austin officer: Controller/Prin Fin&Acct Offic 350 HILLS ST, STE 106, RICHLAND WA 99354
Philip J Vitale director 8849 E. CALLE DE LAS BRISAS, SCOTTSDALE AZ 85255
Michael W Mccormick director 9923 EAST BELL ROAD, STE 130, SCOTTSDALE AZ 85260
William Cavanagh officer: Vice President 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Alan Hoffmann director 3030 EAST CACTUS ROAD, SUITE 101, PHOENIX AZ 85032
Michael Krachon officer: VP of Sales & Marketing 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Krista Cline officer: Dir. of Operations, Secretary 350 HILLS STREET, STE 106, RICHLAND WA 99354
Jennifer Streeter officer: VP of Human Resources 350 HILLS STREET SUITE 106, RICHLAND WA 99354